EE05202B1 - Antitrombootilise toimega polüsahhariidid, millel on vähemalt üks kovalentne side biotiini v?i biotiini derivaadiga - Google Patents
Antitrombootilise toimega polüsahhariidid, millel on vähemalt üks kovalentne side biotiini v?i biotiini derivaadigaInfo
- Publication number
- EE05202B1 EE05202B1 EEP200300114A EEP200300114A EE05202B1 EE 05202 B1 EE05202 B1 EE 05202B1 EE P200300114 A EEP200300114 A EE P200300114A EE P200300114 A EEP200300114 A EE P200300114A EE 05202 B1 EE05202 B1 EE 05202B1
- Authority
- EE
- Estonia
- Prior art keywords
- biotin
- polysaccharides
- covalent bond
- antithrombotic activity
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Communicable Diseases (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Virology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0012094A FR2814463B1 (fr) | 2000-09-22 | 2000-09-22 | Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine |
| PCT/FR2001/002918 WO2002024754A1 (fr) | 2000-09-22 | 2001-09-20 | Polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EE200300114A EE200300114A (et) | 2005-02-15 |
| EE05202B1 true EE05202B1 (et) | 2009-08-17 |
Family
ID=8854579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200300114A EE05202B1 (et) | 2000-09-22 | 2001-09-20 | Antitrombootilise toimega polüsahhariidid, millel on vähemalt üks kovalentne side biotiini v?i biotiini derivaadiga |
Country Status (39)
| Country | Link |
|---|---|
| US (3) | US6844329B2 (cs) |
| EP (1) | EP1322673B1 (cs) |
| JP (2) | JP5016778B2 (cs) |
| KR (2) | KR20080049139A (cs) |
| CN (1) | CN1235914C (cs) |
| AR (1) | AR030774A1 (cs) |
| AT (1) | ATE374215T1 (cs) |
| AU (2) | AU9196001A (cs) |
| BG (1) | BG66191B1 (cs) |
| BR (1) | BR0114007A (cs) |
| CA (1) | CA2418815C (cs) |
| CY (1) | CY1108076T1 (cs) |
| CZ (1) | CZ300856B6 (cs) |
| DE (1) | DE60130669T2 (cs) |
| DK (1) | DK1322673T3 (cs) |
| EA (1) | EA005133B1 (cs) |
| EC (1) | ECSP034514A (cs) |
| EE (1) | EE05202B1 (cs) |
| ES (1) | ES2292625T3 (cs) |
| FR (1) | FR2814463B1 (cs) |
| GE (1) | GEP20053616B (cs) |
| HR (1) | HRP20030219B1 (cs) |
| HU (2) | HU1400034D0 (cs) |
| IL (2) | IL154848A0 (cs) |
| IS (1) | IS2550B (cs) |
| ME (2) | ME00080B (cs) |
| MX (1) | MXPA03002483A (cs) |
| NO (2) | NO332905B1 (cs) |
| NZ (1) | NZ524472A (cs) |
| PE (1) | PE20020471A1 (cs) |
| PL (1) | PL206727B1 (cs) |
| PT (1) | PT1322673E (cs) |
| RS (1) | RS50730B (cs) |
| SI (1) | SI1322673T1 (cs) |
| SK (2) | SK287218B6 (cs) |
| TW (1) | TWI308153B (cs) |
| UA (1) | UA79736C2 (cs) |
| WO (1) | WO2002024754A1 (cs) |
| ZA (1) | ZA200301692B (cs) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2814463B1 (fr) * | 2000-09-22 | 2002-11-15 | Sanofi Synthelabo | Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine |
| FR2874924B1 (fr) | 2004-09-09 | 2006-12-01 | Sanofi Aventis Sa | Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique |
| TWI403334B (zh) * | 2004-12-23 | 2013-08-01 | Merck Sharp & Dohme | 包含生物素殘基之抗血栓雙重抑制劑 |
| TWI376234B (en) * | 2005-02-01 | 2012-11-11 | Msd Oss Bv | Conjugates of a polypeptide and an oligosaccharide |
| UA94593C2 (ru) * | 2005-10-10 | 2011-05-25 | Н.В. Органон | Антитромбозные двойные ингибиторы с биотиновой меткой |
| EP1991271B1 (en) * | 2005-10-10 | 2011-03-09 | N.V. Organon | Anticoagulant antithrombotic dual inhibitors comprising a biotin label |
| CN1317035C (zh) * | 2005-10-24 | 2007-05-23 | 天津大学 | 基于酰肼基的微粒表面多重生物功能因子组装方法 |
| EP1886696A1 (en) * | 2006-08-03 | 2008-02-13 | Endotis Pharma | Conjugates of antithrombin binding oligosaccharide derivatives and therapeutic proteins |
| FR2912409B1 (fr) * | 2007-02-14 | 2012-08-24 | Sanofi Aventis | Heparines de bas poids moleculaire comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine leur procede de preparation,leur utilisation |
| TW201006479A (en) * | 2008-07-18 | 2010-02-16 | Sanofi Aventis | Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment |
| EP2145624A1 (en) | 2008-07-18 | 2010-01-20 | Sanofi-Aventis | Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment |
| EP2233143A1 (en) | 2009-03-24 | 2010-09-29 | Sanofi-Aventis | Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment |
| FR2935386B1 (fr) * | 2008-08-26 | 2010-09-10 | Sanofi Aventis | Nouveaux polysaccharides a activite antithrombotique comprenant une liaion covalente avec une chaine amine |
| CA2735983A1 (en) * | 2008-09-10 | 2010-03-18 | Transpharma Medical Ltd. | Transdermal delivery of oligosaccharides |
| AU2009335709A1 (en) | 2008-12-19 | 2011-07-14 | Supernus Pharmaceuticals, Inc. | Method of treatment of aggression |
| FR2952935B1 (fr) * | 2009-11-20 | 2011-12-02 | Sanofi Aventis | Procede de preparation du n-biotinyl-6-aminocaproate de n succinimidyle |
| WO2011073408A2 (en) | 2009-12-18 | 2011-06-23 | Endotis Pharma | Pharmaceutical oral dosage form containing a synthetic oligosaccharide |
| CZ302510B6 (cs) * | 2010-03-29 | 2011-06-22 | Univerzita Palackého v Olomouci | Efektivní zpusob biotinylace sloucenin s karboxylovou skupinou pomocí syntézy na pevné fázi pro potreby afinitní chromatografie |
| CZ302669B6 (cs) * | 2010-03-29 | 2011-08-24 | Univerzita Palackého v Olomouci | Efektivní zpusob biotinylace aminosloucenin pomocí syntézy na pevné fázi pro potreby afinitní chromatografie |
| EP2552423B1 (en) | 2010-03-31 | 2017-07-12 | Supernus Pharmaceuticals, Inc. | Stabilized formulations of cns compounds |
| FR2964660B1 (fr) * | 2010-09-10 | 2012-09-28 | Sanofi Aventis | Nouveaux polysaccharides biotinyles a activite antithrombotique et presentant une stabilite metabolique amelioree |
| EP2614089A1 (fr) | 2010-09-10 | 2013-07-17 | Sanofi-Aventis | Polysaccharides biotinyles a activite antithrombotique et presentant une stabilite metabolique amelioree |
| EP2484366A1 (en) | 2011-02-07 | 2012-08-08 | Sanofi | Idrabiotaparinux for the treatment of pulmonary embolism and for the secondary prevention of venous thromboembolic events |
| CA2839139A1 (en) | 2011-06-17 | 2012-12-20 | Carbomimetics | Synthetic pentasaccharides having short half-life and high activity |
| WO2014078394A1 (en) * | 2012-11-13 | 2014-05-22 | Supernus Pharmaceuticals, Inc. | Method of treatment of aggression |
| WO2015195404A1 (en) | 2014-06-20 | 2015-12-23 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Methods for detection of an analyte by movement of tethered microparticles |
| WO2016205239A1 (en) | 2015-06-15 | 2016-12-22 | The United States Of America, As Represented By The Secretary Department Of Health And Human Services | Non-hormonal mammalian sperm decoy contraception based on the n-terminus of the zp2 protein |
| CN110234600B (zh) | 2016-10-21 | 2023-03-21 | 美国政府(由卫生和人类服务部的部长所代表) | 分子纳米标签 |
| CN108976318B (zh) * | 2017-06-01 | 2021-03-30 | 首都医科大学 | 单-6-(生物素酰胺基)-6-脱氧-β-环糊精及其制备方法和应用 |
| WO2019133727A1 (en) | 2017-12-29 | 2019-07-04 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Universal influenza virus probe set for enrichment of any influenza virus nucleic acid |
| AU2020310172A1 (en) | 2019-07-09 | 2022-03-03 | Optimvia Llc | Methods for synthesizing anticoagulant polysaccharides |
| WO2021075165A1 (ja) * | 2019-10-17 | 2021-04-22 | 株式会社オートネットワーク技術研究所 | 配線モジュール |
| WO2022056078A1 (en) | 2020-09-11 | 2022-03-17 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Rnase h-assisted detection assay for rna (radar) |
| WO2024191684A1 (en) | 2023-03-10 | 2024-09-19 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Detection of hepatitis c virus ribonucleic acid from whole blood using reverse transcription loop-mediated isothermal amplification |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3960884A (en) * | 1974-04-24 | 1976-06-01 | Sergei Ivanovich Zavyalov | Method of preparing racemic biotin |
| AU563351C (en) * | 1982-01-15 | 2003-06-19 | Glaxo Group Limited | Synthesis of oligosaccharides |
| IL102758A (en) * | 1991-08-23 | 1997-03-18 | Akzo Nv | Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them |
| US20010023288A1 (en) * | 1999-07-07 | 2001-09-20 | Wilbur D. Scott | Trifunctional reagent for conjugation to a biomolecule |
| FR2751334B1 (fr) * | 1996-07-19 | 1998-10-16 | Sanofi Sa | Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant |
| FR2773801B1 (fr) * | 1998-01-19 | 2000-05-12 | Sanofi Sa | Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant |
| FR2773804B1 (fr) * | 1998-01-19 | 2000-02-18 | Sanofi Sa | Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant |
| GB2335490B (en) * | 1998-03-20 | 2003-05-14 | Ortho Clinical Diagnostics | An assay surface that permits an analyte releasiing step |
| AU8366398A (en) * | 1998-07-07 | 2000-01-24 | Department Of Radiation Oncology University Of Washington | Trifunctional reagent for conjugation to a biomolecule |
| WO2000006608A1 (fr) | 1998-07-31 | 2000-02-10 | Seikagaku Corporation | Nouveau glycosaminoglycan et compositions medicamenteuses le contenant |
| FR2814463B1 (fr) * | 2000-09-22 | 2002-11-15 | Sanofi Synthelabo | Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine |
-
2000
- 2000-09-22 FR FR0012094A patent/FR2814463B1/fr not_active Expired - Fee Related
-
2001
- 2001-09-20 AT AT01972171T patent/ATE374215T1/de active
- 2001-09-20 IL IL15484801A patent/IL154848A0/xx unknown
- 2001-09-20 KR KR1020087009747A patent/KR20080049139A/ko not_active Ceased
- 2001-09-20 SK SK5031-2009A patent/SK287218B6/sk not_active IP Right Cessation
- 2001-09-20 EE EEP200300114A patent/EE05202B1/xx not_active IP Right Cessation
- 2001-09-20 CA CA2418815A patent/CA2418815C/en not_active Expired - Fee Related
- 2001-09-20 RS YUP-197/03A patent/RS50730B/sr unknown
- 2001-09-20 BR BR0114007-8A patent/BR0114007A/pt active Search and Examination
- 2001-09-20 ES ES01972171T patent/ES2292625T3/es not_active Expired - Lifetime
- 2001-09-20 CN CNB018161588A patent/CN1235914C/zh not_active Expired - Fee Related
- 2001-09-20 MX MXPA03002483A patent/MXPA03002483A/es active IP Right Grant
- 2001-09-20 DE DE60130669T patent/DE60130669T2/de not_active Expired - Lifetime
- 2001-09-20 HU HUP1400034 patent/HU1400034D0/hu not_active Application Discontinuation
- 2001-09-20 AU AU9196001A patent/AU9196001A/xx active Pending
- 2001-09-20 JP JP2002529162A patent/JP5016778B2/ja not_active Expired - Fee Related
- 2001-09-20 PL PL363368A patent/PL206727B1/pl unknown
- 2001-09-20 ME MEP-2008-236A patent/ME00080B/me unknown
- 2001-09-20 US US10/381,154 patent/US6844329B2/en not_active Expired - Lifetime
- 2001-09-20 SK SK356-2003A patent/SK287054B6/sk not_active IP Right Cessation
- 2001-09-20 ME MEP-236/08A patent/MEP23608A/xx unknown
- 2001-09-20 UA UA2003021719A patent/UA79736C2/uk unknown
- 2001-09-20 NZ NZ524472A patent/NZ524472A/en not_active IP Right Cessation
- 2001-09-20 CZ CZ20030814A patent/CZ300856B6/cs not_active IP Right Cessation
- 2001-09-20 WO PCT/FR2001/002918 patent/WO2002024754A1/fr active Application Filing
- 2001-09-20 HU HU0303551A patent/HUP0303551A3/hu not_active Application Discontinuation
- 2001-09-20 EP EP01972171A patent/EP1322673B1/fr not_active Expired - Lifetime
- 2001-09-20 AU AU2001291960A patent/AU2001291960C1/en not_active Ceased
- 2001-09-20 SI SI200130786T patent/SI1322673T1/sl unknown
- 2001-09-20 EA EA200300237A patent/EA005133B1/ru not_active IP Right Cessation
- 2001-09-20 PT PT01972171T patent/PT1322673E/pt unknown
- 2001-09-20 KR KR1020037004108A patent/KR100891388B1/ko not_active Expired - Fee Related
- 2001-09-20 HR HR20030219A patent/HRP20030219B1/xx not_active IP Right Cessation
- 2001-09-20 AR ARP010104436A patent/AR030774A1/es not_active Application Discontinuation
- 2001-09-20 DK DK01972171T patent/DK1322673T3/da active
- 2001-09-20 GE GE5103A patent/GEP20053616B/en unknown
- 2001-09-21 PE PE2001000952A patent/PE20020471A1/es not_active Application Discontinuation
- 2001-09-21 TW TW090123340A patent/TWI308153B/zh not_active IP Right Cessation
-
2003
- 2003-02-28 IS IS6733A patent/IS2550B/is unknown
- 2003-02-28 ZA ZA200301692A patent/ZA200301692B/en unknown
- 2003-03-10 IL IL154848A patent/IL154848A/en not_active IP Right Cessation
- 2003-03-14 EC EC2003004514A patent/ECSP034514A/es unknown
- 2003-03-20 NO NO20031295A patent/NO332905B1/no not_active IP Right Cessation
- 2003-03-20 BG BG107650A patent/BG66191B1/bg unknown
-
2005
- 2005-01-14 US US11/035,717 patent/US7943595B2/en not_active Expired - Fee Related
-
2007
- 2007-12-04 CY CY20071101542T patent/CY1108076T1/el unknown
-
2011
- 2011-02-28 US US13/036,143 patent/US8318696B2/en not_active Expired - Fee Related
- 2011-03-16 NO NO20110401A patent/NO20110401L/no not_active Application Discontinuation
-
2012
- 2012-02-10 JP JP2012027377A patent/JP2012131809A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE05202B1 (et) | Antitrombootilise toimega polüsahhariidid, millel on vähemalt üks kovalentne side biotiini v?i biotiini derivaadiga | |
| AU2001291960A1 (en) | Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative | |
| NL1002223A1 (nl) | Dilatatiekatheter met zijopening. | |
| ITRM20000041A0 (it) | Derivati glicosamminoglicani parzialmente desolfatati non anticoagulanti ad attivita' antiangiogenica. | |
| DE59909585D1 (de) | Gebläse mit vorgegebener Kennlinie | |
| CA112521S (en) | Plain door | |
| CA106000S (en) | Single x-buck door | |
| ID28773A (id) | Penunjukan-tanah dengan tekanan-sama | |
| FI990842L (fi) | Sovitelma kosketinkiskon yhteydessä | |
| IT1309297B1 (it) | Convogliatore a tasche. | |
| DE69929354D1 (de) | 2,4-disubstierte triazinderivate mit anti-hiv aktivität | |
| JP2000230526A5 (cs) | ||
| DE60021924T2 (de) | Polysaccharide mit immunostimulierender aktivität | |
| FI982740L (fi) | Sovitelma juoksumaton yhteydessä | |
| FI980230A7 (fi) | Sovitelma kulkuneuvon yhteydessä | |
| DK199900347U3 (da) | En brændeovn | |
| SE0000392D0 (sv) | Förbindningsstycke | |
| SK1899U (sk) | Hádzacie šípky s príchytným telesom | |
| IT1309158B1 (it) | Aspirazione a valvole sfasate | |
| IT244919Y1 (it) | Maglie anulari a spessore non costante e catene ornamentali con talimaglie | |
| FI980627L (fi) | Järjestely kokoonpantavan kalusteen yhteydessä | |
| IT247978Y1 (it) | Biscaglina a scalini modificati. | |
| ES1044650Y (es) | Aplique luminoso transformable en percha. | |
| FI4484U1 (fi) | Laitteisto puutavaralokeron yhteydessä | |
| IT1310303B1 (it) | Valvola a lamelle e collettore in gomma costruiti separatamente edassemblati in pezzo unico. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB4A | Valid patent at the end of a year |
Effective date: 20101231 |
|
| MM4A | Lapsed by not paying the annual fees |
Effective date: 20160920 |